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The Saint Vincent Declaration, signed in October 1989 under the aegis of the World Health Organiza tion and the International Diabetes Federation, declared a five year target to 'elaborate, initiate and evaluate comprehensive programmes for detec tion and control of diabetes and of its complications' in order to reduce new blindness by one-third.l Diabetes is the cause of as many as 4000 new cases of blindness in the United States each year and is the leading cause of new blindness in working age adults there, 2 and it has been estimated that screening and treatment (even with current suboptimal care) of type II diabetics saves the United States government $247 million per year? Diabetes is also the com monest cause of blind registration in adults aged 20-65 years in the United Kingdom, and similarly screening proframmes can be demonstrated to be cost-effective. , 5 There is no consensus on the best method of screening, and studies have evaluated community based non-mydriatic polaroid fundus photog raphy,4-9 non-mydriatic hospital-based fundus pho tography,lO,11 hospital-based mydriatic fundus photography,1 2 hospital diabetic physicians, health care workers and general practitioners13-1 8 and ophthalmic opticians,l9-21 as well as other tests such as tritan discrimination sensitivity. 22 This study aimed to compare the performance of an ophthalmic optician with that of an ophthalmology clinical assistant in the detection of diabetic retinopathy requiring referral in a group of diabetic patients from a single group practice.
SUBJECTS AND METHODS
A group practice in Ely, Cambridgeshire, was chosen for this study. The population base was a mix of rural and town dwellers, and the practice covers a population of 15 800. A total of 349 diabetic patients were identified (2.17%) from a review of the practice database. These patients were informed that their eyes would be examined by an experienced clinical assistant in ophthalmology (J.H.) at their annual examination, and at the same time were asked to visit the participating ophthalmic optician (J. W.). Of these patients, 237 (68 %) were examined by both practi tioners independently using pupillary dilatation (1 % cyclopentolate) and direct ophthalmoscopy, slit lamp biomicroscopy using a 78 dioptre lens and indirect ophthalmoscopy where appropriate. The examina tions were carried out in the community ill the GP practice or the optician's shop. The majority of patients were seen by both examiners within a few Eye (1996) 10, 107-112 © 1996 Royal College of Ophthalmologists hours, although a few examinations were separated by a few days; all patients were examined within 2 weeks by both practitioners. Thirty-five patients were examined only by the ophthalmologist and did not attend the optician despite reminders (most patients citing loyalty to their own optician as the reason). These patients are not included in the analysis.
The examiners were asked to classify eyes into background retinopathy (BDR) and diabetic macu lopathy (MP). BDR was divided into mild, moderate and severe, with the latter two being indications for referral to a hospital diabetic retinopathy clinic if not already under ophthalmological review. Severe BDR changes were graded if proliferative retinopathy or pre-proliferative retinopathy were present. Patients were classified as having moderate BDR if, in addition to background changes of microaneurysms, dot haemorrhages and hard exudates, there were deeper blot haemorrhages. MP was divided into minimal, moderate or severe. Minimal MP described any diabetic retinopathy within the temporal arcades, moderate MP was present if there were areas of retinal oedema or hard exudates within two disc diameters of the fovea, and a classification of severe MP was given if the macular oedema or retinopathy directly involved the fovea. The examiners were asked to refer all moderate and severe MP to a hospital diabetic eye clinic if the patients were not under active ophthalmological follow-up. The groups requiring referral to hospital were described as having a sight-threatening condition: moderate or severe BDR or moderate or severe MP.
RESULTS
Of the 474 eyes examined by both ophthalmologist and optician, there was agreement about the presence or absence of any diabetic retinopathy and its grade in 366 eyes (77%). Taking diabetic retinopathy of any sort, the optician found retino pathy in 92 eyes (19%), and 11 of these were felt by the ophthalmologist to be normal (all were graded as mild BDR or minimal MP by the optician and therefore not in the referral group). The ophthalmol ogist diagnosed diabetic retinopathy in 132 eyes 
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(28%). Fifty-five of these were described as normal by the optician; the ophthalmologist graded 53 of these mild BDR and/or minimal MP, but 2 eyes were described as having moderate BDR by the ophthal· mologist and so referred for consideration of laser treatment. Tables I and II illustrate the gradings applied by the ophthalmologist and optician for BDR and MP respectively. The ophthalmologist described BDR in 123 eyes (26%) and the optician in 83 eyes (18 %). Of these patients, both screeners agreed on 73 eyes. The ophthalmologist categorised 49 eyes classed as normal by the optician as having BDR: 47 with mild BDR, and 2 with moderate BDR (and therefore in the referral category). The optician described 11 eyes as having mild BDR, 10 of which the ophthalmologist classed as normal and 1 as moderate BDR and therefore eligible for referral. Of the 12 severe BDR cases classified by the ophthalmologist, the optician described 4 of these as severe and 8 as moderate: all would have therefore been referred to a diabetic eye clinic. A comparison of the ophthal· mologist's and optician's findings is illustrated in Figs. 1 and 2. Of these severe BDR eyes, 10 were already attending a hospital eye clinic and the remaining 2 were referred. The optician would not have referred 3 eyes which the ophthalmologist did refer to the hospital eye service for BDR.
The optician described 45 eyes (9 %) as having MP and the ophthalmologist 63 eyes (13 %). Both agreed on the MP grading for 41 eyes. The remaining 4 eyes graded by the optician as minimal MP were found to have no MP by the ophthalmologist. Twenty-one eyes were graded as normal by the optician but as having MP by the ophthalmologist: 20 of these eyes were graded as minimal MP but 1 was graded as moderate MP by the ophthalmologist, requiring referral to the diabetic eye clinic. In 1 patient the ophthalmologist reported severe MP in both eyes whilst the optician diagnosed drusen. In addition, of the 25 eyes described by the optician as having minimal MP, 3 were found to have severe MP by the ophthalmologist. Figs. 3 and 4 illustrate the findings with regard to maculopathy. There was therefore a significant difference in terms of patients requiring referral for hospital intervention in 6 eyes of 4 patients with maculopathy. Nine of the patients had received laser photo coagulation in a total of 16 eyes (4% of those examined). Eighteen patients (8%) attended a hospital diabetic eye clinic already. Ten patients from this screening study were referred to the diabetic eye clinic: both screeners referred 7 of the cases; 3 patients would not have been referred to the hospital eye service by the optician.
DISCUSSION
The case for developing a screening programme for diabetic retinopathy is overwhelming. Diabetic reti nopathy fulfils the agreed criteria of a disease which is suitable to screen for 2 3 in that it is an important public health problem causing significant morbidity which has a recognisable latent or presymptomatic stage. There exists treatment which is not only effective at reducing blindness but also acceptable to patients and universally applied by ophthalmolo gists around the world. There is cost-benefit analysis to suggest that not only does screening and early treatment benefit the economy by reducing the burden of costs of caring for blind people, but also that patients treated continue to remain economic ally active within the community. Finally, there exist screening tests which are acceptable to patients and professionals alike. However, there is no clear consensus as to the best method of screening in diabetic retinopathy.
The 'gold standard' applied to screening for diabetic retinopathy is seven-field stereo fundus photography or fluorescein angiography, but neither of these is practical as a screening too1. 24 Although fundus examination by a consultant ophthalmologist can be used as a practical standard, it is obvious that in the United Kingdom (and other countries) both limited numbers of ophthalmologists and the struc ture of the health care system (in which there is no open access) mean that this group cannot be used to screen for diabetic retinopathy.25 Even where there are adequate ophthalmologists and general access for the diabetic population, there is a low attendance rate: a study in Nova Scotia found less than 10% of diabetic patients under the age of 50 years were examined? 6 Screening needs to be community-based in order to improve compliance, and accepted wisdom holds that high compliance is essential for a screening programme to be successfulP However, it is not enough to have a screening facility within the community: patients need to be actively recruited and preferably given a specific appointment for screening (in breast cancer screening, it has been shown that a higher compliance rate is achieved with C. J. HAMMOND ET AL.
set appointments rather than open invitation�8).
A study of patients registered blind due to diabetic retinopathy showed that 50% had no screening despite being known to be diabetic? 9 Barrie et al. 30 in Glasgow demonstrated that, despite a concerted campaign to recruit patients within a well-circum scribed population, only 8 % of predicted diabetic patients attended a community-based optometric fundal examination. The general practitioner (GP) lists are the best register of diabetic patients in this country, and with increasing computerisation of practices and establishment of databases to achieve other screening targets, these should be used in conjunction with the screening programme to opti mise compliance.
The majority of presbyopic patients consult an optician, and this could be an important way of improving take-up rates of any screening pro gramme. Our response rate of 68 % in this study was reasonable, and suggests that a screening programme run in conjunction with a GP practice (or, preferably, at the same time as a GP's diabetic clinic if he or she runs one) would have a good compliance.
The sensitivity of any screening test is most important, as the cost of false negatives, i.e. of missing patients who require laser therapy, is expensive. In this study the sensitivity of the optometrist in comparison with the ophthalmologist was 0.92 in the detection of sight-threatening back ground diabetic retinopathy (moderate or severe classifications in our series) and 0.77 in the detection of sight-threatening maculopathy (moderate or severe classifications in our series). These figures compare favourably with other reported screening methods. The specificity of detection of false positive referrals to the hospital eye unit (less important but contributing to the cost-effectiveness of any pro gramme) was 1.0 for the optician in this study: he referred no patients to the hospital eye service which the ophthalmologist did not. Therefore we have found in this study that a well-motivated and trained optician is effective at screening for diabetic retino pathy, and demonstrates remarkable concordance with an ophthalmology clinical assistant. Obviously research would be required to see whether by suitable training, motivation and maintenance of skills, this could be extended to opticians in general.
The cost-effectiveness of any screening method needs to be taken into account, as the choice of method depends on achieving the lowest cost per true positive at acceptable levels of sensitivity and specificity. Costs are difficult to estimate, but one study suggested significant variation between areas of the United Kingdom and methods: £441-£609 for clinical assistants, £784 for ophthalmic opticians, £1033 for hospital physicians and £497-£1159 for photography. All these figures were costs per true positive case detected. 3 1 In our study, we have assumed that costs to the patient of visiting each examiner are the same, as they were both located within a few hundred metres of each other within the community. The cost in examiner's fee can be estimated in our study: the clinical assistant received £56 per session and saw an average of 10 patients per session, while the optician received £13 per patient seen, under the current agreement with the Family Health Service Authorities (although opticians would probably request more in a formal screening service). Although the overhead costs of the opti cian's facility on a main shopping street are likely to be more expensive than those in a GP practice, it must be borne in mind that opticians are already established in the community with appropriate equipment for fundal examination while few GP practices have room or equipment for ophthalmic examination by a clinical assistant in ophthalmology, and so the costs incurred in setting up a screening service would be much higher if the latter were performing the screening.
It has been shown that the cost per true positive for fundal camera screening falls with increasing throughput (up to about 1200 patients screened per annum). 3 1 The optician involved in this study (l.W.) estimates that he sees 500 patients per year. Opticians would need regular training (presumably by consultant ophthalmologists) and regular updates as well as having a regular throughput in order to maintain their diagnostic skills. Unlike a clinical assistant or mobile camera in a G P practice, who might be underutilised if there was a poor atten dance, opticians would have their normal practice to undertake. If ophthalmic opticians were to agree to perform screening for diabetic retinopathy, they would certainly ask for a higher fee than the simple £15 refraction fee currently given, and indeed careful dilated fundoscopy in addition to refraction would take longer than their normal consultation. However, the costs must be cheaper than setting up a totally 'new' screening service with additional personnel and buildings and equipment costs. However, commit ment would be required in terms of money from either purchasers or central government.
CONCLUSION
There are already established guidelines on the requirements for screening for diabetic retinopathy in both Europe 3 2 and the United States. 33 We believe that ophthalmic opticians would be a suitable body to carry out this screening, as they are suitably trained, community-based, already consulted by a large proportion of elderly diabetic patients, and with training can develop appropriate diagnostic skills. However, any screening programme would have to 111 be set up with the assistance of general practitioners, who have the demographic data vital to achieving reasonable compliance rates.
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